Correlation Between Adaptimmune Therapeutics and CEL SCI
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and CEL SCI Corp, you can compare the effects of market volatilities on Adaptimmune Therapeutics and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and CEL SCI.
Diversification Opportunities for Adaptimmune Therapeutics and CEL SCI
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Adaptimmune and CEL is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and CEL SCI go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and CEL SCI
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to generate 0.36 times more return on investment than CEL SCI. However, Adaptimmune Therapeutics Plc is 2.81 times less risky than CEL SCI. It trades about -0.02 of its potential returns per unit of risk. CEL SCI Corp is currently generating about -0.11 per unit of risk. If you would invest 58.00 in Adaptimmune Therapeutics Plc on November 28, 2024 and sell it today you would lose (1.00) from holding Adaptimmune Therapeutics Plc or give up 1.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. CEL SCI Corp
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| CEL SCI Corp |
Adaptimmune Therapeutics and CEL SCI Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and CEL SCI
The main advantage of trading using opposite Adaptimmune Therapeutics and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.The idea behind Adaptimmune Therapeutics Plc and CEL SCI Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| CEL SCI vs. Beam Therapeutics | CEL SCI vs. Editas Medicine | CEL SCI vs. Caribou Biosciences | CEL SCI vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |